A.-M. Teppo

2.2k total citations
55 papers, 1.7k citations indexed

About

A.-M. Teppo is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, A.-M. Teppo has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in A.-M. Teppo's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Systemic Lupus Erythematosus Research (8 papers) and Celiac Disease Research and Management (6 papers). A.-M. Teppo is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Systemic Lupus Erythematosus Research (8 papers) and Celiac Disease Research and Management (6 papers). A.-M. Teppo collaborates with scholars based in Finland, Sweden and United States. A.-M. Teppo's co-authors include C. P. J. Maury, Per‐Henrik Groop, Carol Forsblom, Johan Fagerudd, Markku Saraheimo, Leif Groop, Johan G. Eriksson, Agneta Ekstrand, Kaj Metsärinne and Peter R. Ebeling and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Gut.

In The Last Decade

A.-M. Teppo

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.-M. Teppo Finland 21 370 320 313 278 271 55 1.7k
E. Rosenmann Israel 24 200 0.5× 298 0.9× 466 1.5× 445 1.6× 240 0.9× 168 2.2k
J. A. Charlesworth Australia 29 192 0.5× 683 2.1× 372 1.2× 332 1.2× 624 2.3× 99 2.4k
Jürgen E. Scherberich Germany 22 160 0.4× 422 1.3× 427 1.4× 531 1.9× 247 0.9× 85 1.9k
Anna‐Maija Teppo Finland 24 121 0.3× 516 1.6× 381 1.2× 364 1.3× 463 1.7× 57 2.4k
P Mahieu Belgium 18 101 0.3× 421 1.3× 321 1.0× 334 1.2× 210 0.8× 64 1.6k
Bruce A. Pussell Australia 29 152 0.4× 562 1.8× 292 0.9× 458 1.6× 266 1.0× 87 2.5k
E Taskinen Finland 27 149 0.4× 269 0.8× 297 0.9× 182 0.7× 655 2.4× 152 3.1k
Jean‐Claude Pache Switzerland 27 211 0.6× 379 1.2× 394 1.3× 93 0.3× 747 2.8× 69 2.6k
P Coates Australia 32 295 0.8× 808 2.5× 605 1.9× 334 1.2× 213 0.8× 96 2.7k
Itsuo Gorai Japan 25 173 0.5× 246 0.8× 752 2.4× 91 0.3× 143 0.5× 53 2.4k

Countries citing papers authored by A.-M. Teppo

Since Specialization
Citations

This map shows the geographic impact of A.-M. Teppo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.-M. Teppo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.-M. Teppo more than expected).

Fields of papers citing papers by A.-M. Teppo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.-M. Teppo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.-M. Teppo. The network helps show where A.-M. Teppo may publish in the future.

Co-authorship network of co-authors of A.-M. Teppo

This figure shows the co-authorship network connecting the top 25 collaborators of A.-M. Teppo. A scholar is included among the top collaborators of A.-M. Teppo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.-M. Teppo. A.-M. Teppo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herz, Matthias, et al.. (2007). Pioglitazone has anti-inflammatory effects in patients with Type 2 diabetes. Journal of Endocrinological Investigation. 30(4). 292–297. 14 indexed citations
2.
Teppo, A.-M., et al.. (2006). Inflammation affects lipid metabolism during recovery from hyperinsulinaemia. European Journal of Clinical Investigation. 36(12). 860–865. 3 indexed citations
3.
Teppo, A.-M., T Törnroth, Eero Honkanen, & C Grönhagen-Riska. (2003). Elevated serum C-reactive protein associates with deterioration of renal function in transplant recipients. Clinical Nephrology. 60(10). 248–256. 14 indexed citations
4.
Groop, Per‐Henrik, et al.. (2001). Increased secretion of TGF‐β1 by peripheral blood mononuclear cells from patients with Type 1 diabetes mellitus with diabetic nephropathy. Diabetic Medicine. 18(2). 121–125. 20 indexed citations
5.
Vesaluoma, Minna, et al.. (1999). Soluble Fas and Fas ligand in human tear fluid after photorefractive keratectomy. British Journal of Ophthalmology. 83(12). 1360–1363. 6 indexed citations
6.
Ebeling, Peter R., A.-M. Teppo, Heikki A. Koistinen, et al.. (1999). Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. Diabetologia. 42(12). 1433–1438. 84 indexed citations
7.
Forsblom, Carol, T Sane, Per‐Henrik Groop, et al.. (1998). Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia. 41(11). 1253–1262. 97 indexed citations
8.
Forsblom, Carol, Johan G. Eriksson, Agneta Ekstrand, et al.. (1995). Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia. 38(3). 363–369. 11 indexed citations
9.
10.
Metsärinne, Kaj, Dan Nordström, Yrjö T. Konttinen, A.-M. Teppo, & Frej Fyhrquist. (1992). Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatology International. 12(3). 93–96. 41 indexed citations
11.
Nohynek, Hanna, et al.. (1991). Serum Tumor Necrosis Factor-  Concentrations in Children Hospitalized for Acute Lower Respiratory Tract Infection. The Journal of Infectious Diseases. 163(5). 1029–1032. 18 indexed citations
12.
Gripenberg, M, A.-M. Teppo, & Claes Friman. (1991). Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Rheumatology International. 11(4-5). 209–213. 11 indexed citations
13.
Teppo, A.-M., Kaj Metsärinne, & F Fyhrquist. (1991). Radioimmunoassay of interleukin-6 in plasma. Clinical Chemistry. 37(10). 1691–1695. 24 indexed citations
14.
Groop, Leif, S Stenman, Per‐Henrik Groop, Anne Mäkipernaa, & A.-M. Teppo. (1990). The effect of exercise on urinary excretion of different size proteins in patients with insulin-dependent diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 50(5). 525–532. 9 indexed citations
15.
Gripenberg, M, et al.. (1988). Autoantibody Activity of Cryoglobulins and Sera in Systemic Lupus Erythematosus. Scandinavian Journal of Rheumatology. 17(4). 249–254. 9 indexed citations
16.
Maury, C. P. J., A.-M. Teppo, Matti Vuoristo, Ulla Turunen, & Ismo Virtanen. (1986). Autoantibodies to gliadin-binding 90 kDa glycoprotein in coeliac disease.. Gut. 27(2). 147–152. 8 indexed citations
17.
Maury, C. P. J., J. A. Räsänen, & A.-M. Teppo. (1985). IgM class antibodies to intercellular substance in massive cutaneous hyalinosis: Occurrence and relation to antigluten and antihyalin antibodies. Clinical Immunology and Immunopathology. 34(1). 130–134. 1 indexed citations
18.
Maury, C. P. J. & A.-M. Teppo. (1984). DEMONSTRATION OF TISSUE 90 kD GLYCOPROTEIN AS ANTIGEN IN CIRCULATING IgG IMMUNE COMPLEXES IN DERMATITIS HERPETIFORMIS AND COELIAC DISEASE. The Lancet. 324(8408). 892–894. 18 indexed citations
19.
Maury, C. P. J. & A.-M. Teppo. (1984). Comparative study of serum amyloid-related protein SAA, C-reactive protein, and beta 2-microglobulin as markers of renal allograft rejection.. PubMed. 22(6). 284–92. 34 indexed citations
20.
Helve, T., Pekka Kurki, A.-M. Teppo, & Otto Wegelius. (1983). DNA antibodies and complement in SLE patients. Rheumatology International. 3(3). 129–132. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Rosenmann Breakdown of academic impact, for papers by J. A. Charlesworth Breakdown of academic impact, for papers by Jürgen E. Scherberich Breakdown of academic impact, for papers by Anna‐Maija Teppo Breakdown of academic impact, for papers by P Mahieu Breakdown of academic impact, for papers by Bruce A. Pussell Breakdown of academic impact, for papers by E Taskinen Breakdown of academic impact, for papers by Jean‐Claude Pache Breakdown of academic impact, for papers by P Coates Breakdown of academic impact, for papers by Itsuo Gorai
Rankless by CCL
2026